Diseases, Conditions, Syndromes

Pulmonary fibrosis treatment shows proof of principle

A pre-clinical study led by scientists at Cincinnati Children's demonstrates that in mice the drug barasertib reverses the activation of fibroblasts that cause dangerous scar tissue to build up in the lungs of people with ...

Genetics

New clues to lung-scarring disease may aid treatment

Scientists at Vanderbilt University Medical Center (VUMC) and the Translational Genomics Research Institute (TGen) in Phoenix, Arizona, have discovered previously unreported genetic and cellular changes that occur in the ...

page 11 from 39